Journal of general internal medicine
-
Comparative Study Clinical Trial Controlled Clinical Trial
The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Routine screening for prostate cancer is controversial because of frequent false-positive results, the potential for slow, non-life-threatening growth of untreated cancer, the uncertainty regarding whether treatment can extend life, and the potential for treatment complications. This study examines how information about prostate-specific antigen (PSA) testing and the uncertain benefits of treating prostate cancer affects patients' desire for PSA testing. ⋯ Preference regarding cancer screening and treatment is greatly affected by information about medical uncertainties. Because informed patient choices vary. PSA screening decisions should incorporate individual preferences.